Evidence map›Paper›PMID 32780328›Full record

ReviewNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2020

Young@Heart: empowering the next generation of cardiovascular researchers.

M F Hoes, A S J M Te Riele, M M Gladka, B D Westenbrink, G P J van Hout, M M G van den Hoogenhof, A Ghigo, S Bollini, N H Purcell, S M A Sohaib and 2 more

Abstract readReview
In one paragraph

Review in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

M F HoesYoung@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-0234-438X
A S J M Te RieleYoung@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-1115-6193
M M GladkaYoung@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-4094-4335
B D WestenbrinkDepartment of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
G P J van HoutDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
M M G van den HoogenhofInstitute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-2768-3457
A GhigoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy.
S BolliniEuropean Society of Cardiology, Scientists of Tomorrow, Biot, France.
N H PurcellBasic Cardiovascular Sciences Early Career Committee, American Heart Association, Dallas, TX, USA.
S M A SohaibEuropean Society of Cardiology Board Committee for Young Cardiovascular Professionals, Biot, France.
I KardysYoung@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-2115-9745
D W D KusterYoung@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands. d.kuster@amsterdamumc.nl.ORCID http://orcid.org/0000-0003-1498-6862

Funding

Role of PHLPP in the HeartR01HL114949 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PURCELL, NICOLE H · 2014 to 2022
$3.7M
NHLBI NIH HHS R01 HL114949
6 · The paper itself

Abstract

In recognition of the increasing health burden of cardiovascular disease, the Dutch CardioVascular Alliance (DCVA) was founded with the ambition to lower the cardiovascular disease burden by 25% in 2030. To achieve this, the DCVA is a platform for all stakeholders in the cardiovascular field to align policies, agendas and research. An important goal of the DCVA is to guide and encourage young researchers at an early stage of their careers in order to help them overcome challenges and reach their full potential. Young@Heart is part of the DCVA that supports the young cardiovascular research community. This article illustrates the challenges and opportunities encountered by young cardiovascular researchers in the Netherlands and highlights Young@Heart's vision to benefit from these opportunities and optimise collaborations to contribute to lowering the cardiovascular disease burden together as soon as possible.

Indexed as

Cardiovascular researchDutch CardioVascular AllianceEarly career researchers

Identifiers

PMID32780328
PMCPMC7418282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.